Muscle Loss Clinical Trial
Official title:
The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease
Primary sarcopenia is used to describe aging and progressed with the physiologic decline. Secondary sarcopenia is associated many chronic disease, including acquired immune deficiency syndrome, cancer, chronic heart failure, chronic lung disease, liver cirrhosis, chronic kidney disease and rheumatoid arthritis. In the past, nutrition status is evaluated by body mass index, mid-upper -arm circumference and serum albumin. Bioelectrical impedance analysis is also a common method to measured body composition, but bioelectrical impedance analysis will be affected by tissue edema and ascites. In contrast, cross-section imaging, such as computed tomography and magnetic resonance can analyzed abdominal muscle and fat accurately. Since computed tomography and magnetic resonance imaging can evaluate the severity of polycystic liver and kidney disease. Investigators can use cross section imaging at 3rd lumber level to separate skeletal muscle and fat tissue. Previous studies showed the quantity and quality of abdominal muscle are important prognostic factor after liver transplantation. Besides, chronic kidney disease and receiving renal placement therapy lead protein catabolism and make patients with end stage renal disease have sarcopenia. Finally, patients with polycystic liver and kidney disease have organomegaly, which causes abdominal distention and poor appetite. Therefore, the aim of this study is to observe the association between skeletal muscle mass and the severity of disease and to study whether change in hepatic and renal volumes is associated with change in muscle mass.
The imaging study (CT or MRI) will be performed within one month before the procedure to measure total kidney volume and psoas muscle area. The procedure will use transcatheter embolization to renal artery. The follow-up imaging study will be performed six months after the procedure to measure total kidney volume and psoas muscle area.. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04207359 -
Effects of Creatine Supplementation in Breast Cancer Survivors
|
N/A | |
Completed |
NCT05999266 -
The Cartilage and Muscle Thickness on Knee Pain in Patients With Rheumatoid Arthritis
|
||
Completed |
NCT05531305 -
Longitudinal Changes in Muscle Mass After Intensive Care
|
N/A | |
Completed |
NCT04597983 -
Effect of 8-week Intake of 2S-hesperidin on Performance, Body Composition and Biochemicals Markers in Amateur Cyclists
|
N/A | |
Completed |
NCT01292395 -
Effects of Dietary Protein on Musculoskeletal Health During Calorie Deficiency
|
N/A | |
Completed |
NCT00755638 -
A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 (ActRIIB-IgG1)in Healthy Postmenopausal Volunteers
|
Phase 1 | |
Completed |
NCT04546048 -
The Early Strength Training Program in Post-transplant Liver Cases
|
N/A | |
Recruiting |
NCT05570474 -
Effect of Protein Supplementation on Fat Free Mass Preservation After Bariatric Surgery
|
N/A | |
Completed |
NCT05497960 -
Vivo Prediabetes Study: Online, Live, and Interactive Strength Training for Older Adults With Prediabetes
|
N/A | |
Completed |
NCT04422665 -
Preventing Bed-rest Induced Muscle Loss in the Elderly
|
N/A | |
Completed |
NCT05088304 -
GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric Cancer
|
||
Completed |
NCT03400046 -
The Correlation Between Nutrients and Muscle Mass
|
N/A | |
Completed |
NCT01894737 -
The Effect of Creatine on Muscle Loss
|
N/A | |
Completed |
NCT01714479 -
Skeletal Muscle Response to Amino Acids and Load Carriage Exercise
|
N/A | |
Completed |
NCT05072652 -
Short Term Immobilization of the Lower Limb
|
N/A | |
Completed |
NCT04661618 -
A Randomized-Control Study of Gym Tonic's Community Based Strength Training Intervention.
|
N/A | |
Completed |
NCT05009654 -
The Effect of Leucine on Carnitine Transport to Skeletal Muscle
|
N/A | |
Recruiting |
NCT05795556 -
Biomarkers of Sarcopenia and Frailty in Geriatric Patients
|
||
Completed |
NCT04151108 -
Biomarkers for Length of Hospital Stay and Loss of Muscle Mass and Function in Old Medical Patients
|
||
Recruiting |
NCT05815017 -
YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility
|
N/A |